Product Information
LITHIUM CARBONATE 300 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0959 per EA under NDC 62332001491. Its NADAC has been published 396 times since Nov 28, 2018.
Strength
300 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001491
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA079159On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE 300 MG CAP has been published 396 times since Nov 28, 2018, and over the history we have for it it has risen 105.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0959 per EA |
|---|---|
| All-time high | $0.1240 (Mar 13, 2024) |
| All-time low | $0.0458 (Nov 20, 2019) |
| 52-week high | $0.1151 |
| 52-week low | $0.0926 |
| Median price | $0.0526 |
| Average price | $0.0703 |
| Largest weekly change | +43.9% (Aug 23, 2023) |
| Weeks tracked | 396 |
| Tracking since | Nov 28, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE 300 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 300 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.0959 per EA (NDC 62332001491), effective Jun 24, 2026.
How has the price of LITHIUM CARBONATE 300 MG CAP changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE 300 MG CAP has risen 105.2%. It has been tracked across 396 weekly CMS publications since Nov 28, 2018.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 300 MG CAP?
Since Nov 28, 2018, the NADAC for LITHIUM CARBONATE 300 MG CAP has ranged from a low of $0.0458 (Nov 20, 2019) to a high of $0.1240 (Mar 13, 2024), with a median of $0.0526 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE 300 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LITHIUM CARBONATE 300 MG CAP, but none are currently priced below it.
Who manufactures LITHIUM CARBONATE 300 MG CAP?
LITHIUM CARBONATE 300 MG CAP (NDC 62332001491) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification